Cyclacel Pharmaceuti (CYCCP)
Cyclacel Pharmaceuti (CYCCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYCCP | ||||
| Company | Cyclacel Pharmaceuti | ||||
| Price Information | |||||
| Exchange | NASDAQ | ||||
| Open | 5.35 | ||||
| High | 5.60 | ||||
| Low | 5.05 | ||||
| Latest | 5.05 | ||||
| Change | -0.23 | ||||
| % Change | -4.36% | ||||
| Volume | 6,400 | ||||
| 20-Day Average Volume | 6,705 | ||||
| Previous Close | 5.28 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 5.03 | ||||
| 20-Day Raw Stochastic | 29.43% | ||||
| 20-Day Relative Strength | 50.76 | ||||
| Weighted Alpha | -42.25 | ||||
| Today's Opinion | 32% Sell | ||||
| Previous Opinion | 40% Sell | ||||
| Last Month's Opinion | 88% Sell | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.26% since 09/04/25 | ||||
| Low | 4.67 on 09/05/25 | ||||
| High | 5.72 on 09/10/25 | ||||
| 1-Month | |||||
| %Chg | +16.63% since 08/08/25 | ||||
| Low | 4.07 on 08/13/25 | ||||
| High | 7.40 on 08/14/25 | ||||
| 3-Month | |||||
| %Chg | -11.40% since 06/11/25 | ||||
| Low | 4.04 on 08/06/25 | ||||
| High | 7.40 on 08/14/25 | ||||
| 6-Month | |||||
| %Chg | -8.18% since 03/11/25 | ||||
| Low | 3.29 on 04/08/25 | ||||
| High | 7.40 on 08/14/25 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | ||||
| Shares Outstanding, K | N/A | ||||
| Annual Sales | 43,000 | ||||
| Annual Net Income | -11,212,000 | ||||
| Last Quarter Sales | 0 | ||||
| Last Quarter Net Income | -1,318,000 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | 12/31/14 | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||